Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-06-05
1996-06-25
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546187, A61K 31445, C07D40114
Patent
active
055300090
ABSTRACT:
This invention provides novel compound of the formula ##STR1## which is neurokinin receptor antagonist.
REFERENCES:
patent: 4751506 (1988-06-01), Ciganek et al.
patent: 5182282 (1993-01-01), Clemence
patent: 5300648 (1994-04-01), Emonds-Alt
patent: 5350852 (1994-09-01), Emonds-Alt
patent: 5446052 (1995-08-01), Emonds-Alt
Budurow et al. Tetrahedron Letters, vol. 30, pp.2321-2324 (1989).
Chen et al, Can. J. Chem. 65 pp. 611-625 (1987).
Nagasaka et al, Heterocycles 27, pp. 2219-2224 (1988).
Strazewski et al, Synthesis, pp. 218-249 (1987).
Hispskind et al. "Pharmacological characterization of LY 303870: a novel potent and selective nonpeptide substance P receptor antagonist" Pharmcol. Exp. Ther. v. 275, pp. 737-744 (1995).
Cho Sung Yong S.
Copp James D.
Ginah Francis O.
Hansen Guy J.
Hipskind Philip A.
Boone David E.
Chang Ceila
Eli Lilly and Company
Gaylo Paul J.
LandOfFree
Bis-piperidinyl non-peptidyl neurokinin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bis-piperidinyl non-peptidyl neurokinin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bis-piperidinyl non-peptidyl neurokinin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2189043